Cargando…
Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984333/ https://www.ncbi.nlm.nih.gov/pubmed/27582888 http://dx.doi.org/10.1177/1756283X16654499 |
_version_ | 1782447958384443392 |
---|---|
author | Fukuda, Daisuke Akazawa, Yuko Takeshima, Fuminao Nakao, Kazuhiko Fukuda, Yutaka |
author_facet | Fukuda, Daisuke Akazawa, Yuko Takeshima, Fuminao Nakao, Kazuhiko Fukuda, Yutaka |
author_sort | Fukuda, Daisuke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4984333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-49843332016-09-01 Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients Fukuda, Daisuke Akazawa, Yuko Takeshima, Fuminao Nakao, Kazuhiko Fukuda, Yutaka Therap Adv Gastroenterol Letters to the Editor SAGE Publications 2016-06-20 2016-09 /pmc/articles/PMC4984333/ /pubmed/27582888 http://dx.doi.org/10.1177/1756283X16654499 Text en © The Author(s), 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Letters to the Editor Fukuda, Daisuke Akazawa, Yuko Takeshima, Fuminao Nakao, Kazuhiko Fukuda, Yutaka Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title | Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title_full | Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title_fullStr | Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title_full_unstemmed | Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title_short | Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients |
title_sort | safety and efficacy of vonoprazan-based triple therapy against helicobacter pylori infection: a single-center experience with 1118 patients |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984333/ https://www.ncbi.nlm.nih.gov/pubmed/27582888 http://dx.doi.org/10.1177/1756283X16654499 |
work_keys_str_mv | AT fukudadaisuke safetyandefficacyofvonoprazanbasedtripletherapyagainsthelicobacterpyloriinfectionasinglecenterexperiencewith1118patients AT akazawayuko safetyandefficacyofvonoprazanbasedtripletherapyagainsthelicobacterpyloriinfectionasinglecenterexperiencewith1118patients AT takeshimafuminao safetyandefficacyofvonoprazanbasedtripletherapyagainsthelicobacterpyloriinfectionasinglecenterexperiencewith1118patients AT nakaokazuhiko safetyandefficacyofvonoprazanbasedtripletherapyagainsthelicobacterpyloriinfectionasinglecenterexperiencewith1118patients AT fukudayutaka safetyandefficacyofvonoprazanbasedtripletherapyagainsthelicobacterpyloriinfectionasinglecenterexperiencewith1118patients |